½ÃÀ庸°í¼­
»óǰÄÚµå
1717918

´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç° À¯Çü, °Ë»ç À¯Çü, ÃøÁ¤ ÆÄ¶ó¹ÌÅÍ, ¿¬·ÉÃþ, È޴뼺, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Metabolic Testing Solutions Market by Product Type, Test Type, Measurement Parameter, Age Group, Portability, Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀåÀº 2024³â¿¡´Â 7¾ï 3,548¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2025³â¿¡´Â 7¾ï 8,299¸¸ ´Þ·¯, CAGR 6.74%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 10¾ï 8,837¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ 2024³â 7¾ï 3,548¸¸ ´Þ·¯
ÃßÁ¤ ¿¬µµ 2025³â 7¾ï 8,299¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ 2030³â 10¾ï 8,837¸¸ ´Þ·¯
CAGR(%) 6.74%

´ë»ç °Ë»ç ¼Ö·ç¼ÇÀº Áø´Ü ¹æ¹ýÀÇ ¹ßÀüÀÇ Ãʼ®À¸·Î µîÀåÇÏ¿© ÀÇ·á, °Ç°­, ¿îµ¿ ´É·Â Æò°¡ÀÇ ÃÖÀü¼±¿¡ Á¤È®¼º°ú ÀÎü »ý¸®Çп¡ ´ëÇÑ ±íÀº ÀÌÇØ¸¦ °¡Á®´ÙÁÖ¾ú½À´Ï´Ù. ÀÌ ºÐ¾ß´Â ±âº»ÀûÀÎ Áø´Ü Å×½ºÆ®¿¡¼­ °í±Þ Çϵå¿þ¾î¿Í Á¤±³ÇÑ ¼ÒÇÁÆ®¿þ¾î ¾ÖÇø®ÄÉÀ̼ÇÀ» °áÇÕÇÑ ÅëÇÕ Ç÷§ÆûÀ¸·Î ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç, »ó¼¼ÇÏ°í °³ÀÎÈ­µÈ ´ë»ç µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù »ý¹° ÀÇÇÐ °øÇÐ ¹× °è»ê ºÐ¼®ÀÇ ºñ¾àÀûÀÎ ¹ßÀüÀº ´ë»ç Æò°¡ÀÇ Á¤È®µµ¸¦ Çâ»ó½ÃÄ×À» »Ó¸¸ ¾Æ´Ï¶ó ÀÓ»ó Áø´Ü, °Ç°­ ÁõÁø ÇÁ·Î±×·¥, ½ºÆ÷Ã÷ ÀÇÇÐ, Àα¸ Á¶»ç µî ±× Àû¿ë ¹üÀ§¸¦ ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ¹ßÀüÀº Àü¹®°¡, ¿¬±¸ÀÚ ¹× ÃÖÁ¾»ç¿ëÀÚ°¡ ´ë»ç °Ç°­ »óŸ¦ ÀνÄÇÏ´Â ¹æ½ÄÀ» ÀçÁ¤ÀÇÇϰí, Áúº´ °ü¸® ¹× ÇÇÆ®´Ï½º ÇÁ·Î±×·¥¿¡ ´ëÇÑ Àû±ØÀûÀÎ °³ÀÔÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ±â¼ú µ¿ÇâÀ» µµÀÔÇÔÀ¸·Î½á ¿©·¯ °Ë»ç ¹æ¹ý·ÐÀÇ µ¥ÀÌÅ͸¦ ¿øÈ°ÇÏ°Ô ÅëÇÕÇÏ¿© °á°ú¸¦ Æ÷°ýÀûÀÌ°í ½Ç¿ëÀûÀ¸·Î º¸ÀåÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ȯÀÚ ¹× ¼ÒºñÀÚ Áß½ÉÀÇ ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀ» ¹Ý¿µÇÏ´Â ¾÷°è µ¿Çâ¿¡ µû¶ó ÀÌ ºÐ¾ß´Â ÷´Ü °úÇаú ÀÏ»óÀûÀÎ °Ç°­ ÀλçÀÌÆ® »çÀÌÀÇ °£±ØÀ» ¸Þ¿ï ¼ö ÀÖ´Â ÆÐ·¯´ÙÀÓÀÇ ÀüȯÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

½ÅÁø´ë»çÀÇ º¹À⼺À» ÀÌÇØÇÏ´Â µ¥ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌÇØ°ü°èÀÚµéÀº ¿¹¹æ ÀÇÇÐÀÇ »õ·Î¿î ÀáÀç·ÂÀ» ¹ß°ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÌ ¼º¼÷ÇØÁü¿¡ µû¶ó ´Ù¾çÇÑ °Ë»ç Á¢±Ù ¹æ½Ä°ú Á¦Ç° Á¦°øÀº Á¡Á¡ ´õ Á¤±³ÇØÁö´Â °í°´ ±â¹Ý¿¡ ´ëÀÀÇÏ¿© ´ë»ç °Ë»ç°¡ ÇコÄɾî Çõ½ÅÀÇ ÃÖ÷´Ü¿¡ ¼­µµ·Ï º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀåÀÇ º¯È­

´ë»ç °Ë»çÀÇ »óȲÀº ±Þ¼ÓÇÑ ±â¼ú Çõ½Å, ¼ÒºñÀÚ ±â´ëÄ¡ÀÇ º¯È­, µðÁöÅÐ µµ±¸ÀÇ ÅëÇÕ °­È­¿¡ ÈûÀÔ¾î Å« º¯È­ÀÇ ½Ã±â¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ¼¾¼­ ±â¼ú, µ¥ÀÌÅÍ ºÐ¼®, ¸Ó½Å·¯´×ÀÇ »õ·Î¿î Æ®·»µå´Â °Ë»ç Á¤È®µµ¸¦ Å©°Ô Çâ»ó½Ã۰í, ´ë»ç ±â´É¿¡ ´ëÇÑ º¸´Ù Æ÷°ýÀûÀÌ°í ½Ç½Ã°£ÀûÀÎ ÀλçÀÌÆ®¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ±âÁ¸ÀÇ Á¢±Ù ¹æ½ÄÀ» ÇØÃ¼Çϰí, Áø´ÜÀÌ º¸´Ù ½Å¼ÓÇÒ »Ó¸¸ ¾Æ´Ï¶ó, º¸´Ù ¿¹ÃøÀûÀÌ°í °³º°È­µÈ Áø´ÜÀÌ °¡´ÉÇÑ »õ·Î¿î ½Ã´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Áß¿äÇÑ º¯È­ Áß Çϳª´Â Çϵå¿þ¾î¿Í ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÌ ÇϳªÀÇ ÅëÇÕÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î Ç÷§ÆûÀ¸·Î ÅëÇÕµÈ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº °Ë»ç ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ´Â µ¿½Ã¿¡ Áø´Ü µ¥ÀÌÅÍÀÇ Ç°ÁúÀ» Çâ»ó½Ã۱⠶§¹®¿¡ °ÔÀÓ Ã¼ÀÎÀú·Î ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·áÀÇ Ãß¼¼´Â ´ë»ç °Ë»ç ¼Ö·ç¼ÇÀÌ °³ÀÎÀÇ »ý¸®Àû Â÷À̸¦ °í·ÁÇÏ¿© ¼³°èµÇ¾î ´õ ³ªÀº °Ç°­ °á°ú¿Í ȯÀÚÀÇ °æ°ú¸¦ ÀϰüµÇ°Ô ¸ð´ÏÅ͸µÇÏ´Â °ÍÀ¸·Î À̾îÁø´Ù´Â Á¡¿¡¼­ ºÐ¸íÇÏ°Ô µå·¯³³´Ï´Ù.

¶ÇÇÑ, ÀÓ»ó Áø´Ü°ú ¼ÒºñÀÚ °Ç°­ °ü¸® Ç÷§ÆûÀÇ À¶ÇÕÀº ÀÌ·¯ÇÑ °Ë»çÀÇ Á¢±Ù¼ºÀ» ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù. ÀÓ»óÀÇ, ÇÇÆ®´Ï½º Àü¹®°¡, ¿¬±¸ÀÚµéÀº ÇöÀç Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å, ½Ç½Ã°£ ÀÇ»ç°áÁ¤, ´Ù¾çÇÑ ºÎ¼­ °£ ¼ÒÅë °­È­¸¦ Áö¿øÇÏ´Â »ýŰèÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ±â¹Ý ÀλçÀÌÆ®°¡ ÀÏ»óÀûÀÎ °Ç°­ ½À°ü¿¡ ÅëÇյǸé ÃÖÁ¾»ç¿ëÀÚ¿¡°Ô ÈûÀ» ½Ç¾îÁÙ »Ó¸¸ ¾Æ´Ï¶ó, ¿¬±¸¿Í Á¦Ç° °³¹ßÀÇ »õ·Î¿î ±æÀ» ¿­¾î ¾÷°èÀÇ À繫 ¹× °æ¿µ ¸ðµ¨À» À籸¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®ÀÌ ½ÃÀå Àü·«¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

´ë»ç °Ë»ç ¼Ö·ç¼Ç ºÐ¾ßÀÇ ½ÃÀå ¼¼ºÐÈ­¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¸é ´Ù¾çÇÑ Á¦Ç° À¯Çü, °Ë»ç ¹æ½Ä, ÃøÁ¤ ¸Å°³º¯¼ö, ¿¬·É´ë, È޴뼺, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹üÁÖ¸¦ ÅëÇÕÇÏ´Â º¹ÀâÇÑ ÇÁ·¹ÀÓ¿öÅ©°¡ µå·¯³³´Ï´Ù. »ê¾÷Àº Á¦Ç° À¯Çü¿¡ µû¶ó µð¹ÙÀ̽º¿Í ¼ÒÇÁÆ®¿þ¾î ¹× ¾ÛÀ¸·Î ±¸ºÐµÇ¸ç, ÀüÀÚ´Â ´Ù½Ã ´Ù¿ëµµ ½Ã½ºÅÛ°ú ÀÏȸ¿ë ½Ã½ºÅÛÀ¸·Î ³ª´¹´Ï´Ù. ÀÌ Â÷¿øÀº ÅëÇÕ ¼Ö·ç¼ÇÀÌ ´Ù¾çÇÑ Áø´Ü ¿ä°ÇÀ» ÃæÁ·ÇÏ°í ´Ù¾çÇÑ ÀÓ»ó ÇöÀå°ú ¼ÒºñÀÚ È¯°æ¿¡ ´ÙÀç´Ù´ÉÇÔÀ» Á¦°øÇϱâ À§ÇØ ÁøÈ­ÇØ ¿ÔÀ½À» ¹Ý¿µÇÕ´Ï´Ù.

°Ë»ç À¯ÇüÀ» ÀÚ¼¼È÷ »ìÆìº¸¸é, ½ÃÀåÀº »ýÈ­ÇÐ °Ë»ç, È£Èí °Ë»ç, À¯ÀüÀÚ °Ë»ç¸¦ Æ÷ÇÔÇÑ ºÎ¹®À¸·Î ±¸ºÐµË´Ï´Ù. »ýÈ­ÇÐ °Ë»ç´Â Ç÷¾× ºÐ¼®, Ÿ¾× °Ë»ç, ¼Òº¯ ºÐ¼®À¸·Î ³ª´µ¸ç, °¢ »ýü¾×ÀÌ ´ë»ç °úÁ¤¿¡ ´ëÇÑ °íÀ¯ÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â ¹æ¹ýÀ» °­Á¶ÇÕ´Ï´Ù. ¹Ý¸é, È£Èí °Ë»ç´Â ¾ÈÁ¤½Ã ´ë»çÀ² ÃøÁ¤ ¹× VO2max °Ë»ç¿Í °°Àº Æò°¡¿¡ ´ëÀÀÇϸç, °¢°¢Àº ƯÁ¤ ÀÓ»óÀû ¿ä±¸ ¶Ç´Â ¼º´É ±â¹Ý ¿ä±¸¿¡ ´ëÀÀÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±¸ºÐÀº ´Ù¾çÇÑ ÀÓ»ó ÀÀ¿ë ºÐ¾ßÀÇ Æ¯Á¤ ¿ä±¸ »çÇ×À» ÃæÁ·Çϵµ·Ï Áø´Ü Á¦Ç°À» Á¶Á¤ÇÏ´Â °ÍÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

ÃøÁ¤ ¸Å°³ º¯¼ö¿¡ µû¸¥ Ãß°¡ ¼¼ºÐÈ­¿¡´Â È£Èí »ó¼ö, ÈÞ½Ä ´ë»çÀ², ±âÁú ÀÌ¿ë·ü, ÃÑ ¿¡³ÊÁö ¼Òºñ·® µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ÁöÇ¥¸¦ ±â¹ÝÀ¸·Î ÇÑ ºÐ·ù´Â °³ÀÎÀÇ ´ë»ç È¿À²°ú ¿¡³ÊÁö µ¿¿ªÇÐÀ» ±íÀÌ ÀÌÇØÇÒ ¼ö Àֱ⠶§¹®¿¡ Á¤¹Ð Áø´Ü¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ½ÃÀåÀº û¼Ò³â±â, ¼ºÀαâ, ³ë³â±â, ¼Ò¾Æ±â µî ¿¬·É´ëº°·Î ±¸ºÐµÇ¾î ÀÖ¾î, ÀÏ»ý µ¿¾È ¹ß»ýÇÏ´Â »ý¸®Àû º¯È­¿¡ µû¶ó °Ë»ç ÇÁ·ÎÅäÄÝÀ» Á¶Á¤ÇÒ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¼¼ºÐÈ­ Àü·«Àº È޴뼺À» °í·ÁÇÏ¿© º¥Ä¡Å¾Çü°ú ÈÞ´ë¿ëÀ¸·Î ±¸ºÐÇϰí È޴뼺À» °í·ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±¸ºÐÀº ÀÓ»ó ȯ°æ¿¡¼­ÀÇ ´ë¿ë·® °Ë»ç ¼³Á¤°ú ¿ø°ÝÁö ¹× °¡Á¤ ³» Áø´ÜÀ» À§ÇÑ À¯¿¬ÇÑ ¸ð¹ÙÀÏ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù. ÀÀ¿ë ºÐ¾ßº°·Î º¸¸é ´ë»ç °Ë»ç´Â ÀÓ»ó Áø´Ü, °Ç°­ ¹× À£´Ï½º, Àα¸ Á¶»ç, ½ºÆ÷Ã÷ ¹× ÇÇÆ®´Ï½º, ±×¸®°í °¢ Ä«Å×°í¸® ³»¿¡¼­ ´õ¿í ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÀÓ»ó Áø´ÜÀº º´¿ø, ¿¬±¸¼Ò, Àü¹® Ŭ¸®´Ð, °Ç°­ ¹× À£ºùÀº ÇコÀå ¹× Ã¼Áß °ü¸® ½Ã¼³, Àα¸ Á¶»ç´Â ¿ªÇÐ Á¶»ç ¹× ¿µ¾ç Á¶»ç, ½ºÆ÷Ã÷ ¹× ÇÇÆ®´Ï½º´Â ¾Æ¸¶Ãß¾î ¿îµ¿¼±¼ö, ÇÇÆ®´Ï½º ¾ÖÈ£°¡, ÇÁ·Î ¿îµ¿¼±¼ö·Î ³ª´¹´Ï´Ù.

¸¶Áö¸·À¸·Î, ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¸¥ ½ÃÀå ¼¼ºÐÈ­¿¡´Â ÇÇÆ®´Ï½º ¼¾ÅÍ ¹× üÀ°°ü, ȨÄɾî ȯ°æ, º´¿ø ¹× Ŭ¸®´Ð, ¿¬±¸¼Ò, ½ºÆ÷Ã÷ ¾ÆÄ«µ¥¹Ì, ÇÇÆ®´Ï½º üÀÎ ¹× °³ÀÎ Æ®·¹ÀÌ´× ½Ã¼³, û¼Ò³â Æ®·¹ÀÌ´× ±â°ü°ú ÇÔ²² ÇÁ·Î ¼±¼ö ¼¾ÅͰ¡ Æ÷ÇԵ˴ϴÙ. µîÀÇ ºÎ¹®À¸·Î ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼¼ºÐÈ­¸¦ ÅëÇØ ¾÷°è ÀÌÇØ°ü°èÀÚµéÀº Ÿ±ê °í°´À» Á¤È®È÷ ÆÄ¾ÇÇϰí, ÇöÀç Æ®·»µå¿Í ÇâÈÄ ½ÃÀå °³¹ß ¼ö¿ä¿¡ ¸Â´Â Àü·«À» ¼ö¸³ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter¡¯s Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç° À¯Çüº°

  • µð¹ÙÀ̽º
    • ´Ù¸ñÀû
    • ÀÏȸ¿ë
  • ¼ÒÇÁÆ®¿þ¾î¿Í ¾Û

Á¦7Àå ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : Å×½ºÆ® Á¾·ùº°

  • »ýÈ­ÇÐ °Ë»ç
    • Ç÷¾× °Ë»ç
    • Ÿ¾× °Ë»ç
    • ¼Òº¯ °Ë»ç
  • È£±â °Ë»ç
    • ¾ÈÁ¤ ½Ã´ë»çÀ² ÃøÁ¤
    • VO2 Max Å×½ºÆ®
  • À¯ÀüÀÚ °Ë»ç

Á¦8Àå ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : ÃøÁ¤ ÆÄ¶ó¹ÌÅͺ°

  • È£Èí»ó
  • ¾ÈÁ¤ ½Ã´ë»çÀ²
  • ±âÁú ÀÌ¿ë
  • ÃÑ ¿¡³ÊÁö ¼Òºñ·®

Á¦9Àå ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : ¿¬·ÉÃþº°

  • û¼Ò³â±â
  • ¼ºÀοë
  • ³ëÀÎ
  • ¼Ò¾Æ°ú

Á¦10Àå ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : È޴뼺º°

  • º¥Ä¡Å¾ ½Ã½ºÅÛ
  • ÈÞ´ë¿ë ½Ã½ºÅÛ

Á¦11Àå ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : ¿ëµµº°

  • ÀÓ»ó Áø´Ü
    • º´¿ø
    • ¿¬±¸¼Ò
    • Àü¹® Ŭ¸®´Ð
  • °Ç°­°ú À£´Ï½º
    • Áü
    • üÁß °ü¸®
  • Àα¸ ¿¬±¸
    • ¿ªÇÐÀû{
    • ¿µ¾çÇÐ ¿¬±¸
  • ½ºÆ÷Ã÷¿Í ÇÇÆ®´Ï½º
    • ¾Æ¸¶Ãß¾î ¿îµ¿¼±¼ö
    • ÇÇÆ®´Ï½º ¾ÖÈ£°¡
    • ÇÁ·Î ¿îµ¿¼±¼ö

Á¦12Àå ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ÇÇÆ®´Ï½º ¼¾ÅÍ¿Í Áü
    • ÇÇÆ®´Ï½º üÀÎ
    • ÆÛ½º³Î Æ®·¹ÀÌ´× ½Ã¼³
  • ÀçÅà ÄÉ¾î ¼³Á¤
  • º´¿ø°ú Áø·á¼Ò
  • Á¶»ç½Ç
  • ½ºÆ÷Ã÷ ¾ÆÄ«µ¥¹Ì
    • ÇÁ·Î ¿îµ¿¼±¼ö ¼¾ÅÍ
    • û¼Ò³â ÈÆ·Ã±â°ü

Á¦13Àå ¾Æ¸Þ¸®Ä«ÀÇ ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦14Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦15Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ´ë»ç °Ë»ç ¼Ö·ç¼Ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • Æ¢¸£Å°¿¹
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2024
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • AEI Technologies, Inc.,
  • Agilent Technologies, Inc
  • BASF SE
  • Biospace, Inc.
  • CENTOGENE N.V.
  • COSMED srl
  • GE HealthCare
  • Geratherm Medical AG
  • ICON plc
  • Iworx Systems
  • KORR Medical Technologies, Inc
  • MGC Diagnostics Corporation
  • Microlife Medical Home Solutions, Inc.,
  • Nicci Schock LLC
  • Parvo Medics
  • PerkinElmer Inc.
  • The Endurance Edge, LLC
  • Thermo Fisher Scientific Inc.
  • Vacumetrics Inc
  • Vyaire Medical, Inc.
ksm 25.05.20

The Metabolic Testing Solutions Market was valued at USD 735.48 million in 2024 and is projected to grow to USD 782.99 million in 2025, with a CAGR of 6.74%, reaching USD 1,088.37 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 735.48 million
Estimated Year [2025] USD 782.99 million
Forecast Year [2030] USD 1,088.37 million
CAGR (%) 6.74%

Metabolic testing solutions have emerged as a cornerstone in the advancement of diagnostic methodologies, bringing precision and a deeper understanding of human physiology to the forefront of medical, wellness, and athletic performance assessments. This field has rapidly evolved from basic diagnostic tests to integrated platforms that combine advanced hardware and sophisticated software applications, addressing the growing demand for detailed and personalized metabolic data. In recent years, breakthroughs in biomedical engineering and computational analytics have not only enhanced the accuracy of metabolic assessments but also broadened their applications across clinical diagnostics, health and wellness programs, sports medicine, and population studies.

These advancements are redefining how practitioners, researchers, and end users perceive metabolic health, allowing for proactive interventions in disease management and tailored fitness programs. The incorporation of novel technological trends enables the seamless integration of data from multiple testing modalities, ensuring that results are both comprehensive and actionable. As industry trends reflect a transition towards more patient- and consumer-centric solutions, the field is poised to drive a paradigm shift, bridging the gap between advanced science and everyday health insights.

The growing interest in understanding the intricacies of metabolism has led to increased investments in research and development, with stakeholders eager to unlock new potential in preventative health. As the market matures, the multiplicity of testing approaches and product offerings caters to an increasingly sophisticated customer base, ensuring that metabolic testing remains at the cutting edge of healthcare innovation.

Transformative Shifts in the Metabolic Testing Landscape

The landscape of metabolic testing is undergoing a profound transformation, propelled by rapid technological innovations, shifting consumer expectations, and enhanced integration of digital tools. Emerging trends in sensor technology, data analytics, and machine learning have substantially improved test precision, enabling more comprehensive and real-time insights into metabolic function. These advancements are dismantling traditional approaches and fostering a new era where diagnostics are not only faster but also more predictive and tailored to individual needs.

One of the key transformative shifts is the consolidation of hardware and software solutions into cohesive, user-friendly platforms. This integration is proving to be a game changer, as it simplifies the testing process while simultaneously elevating the quality of diagnostic data. The trend towards personalized medicine is evident in the way metabolic testing solutions are being designed to account for individual physiological differences, leading to better health outcomes and more consistent monitoring of patient progress.

Moreover, the convergence of clinical diagnostics with consumer health management platforms has redefined the accessibility of these tests. Clinicians, fitness professionals, and researchers now benefit from an ecosystem that supports continuous innovation, real-time decision-making, and enhanced communication across various sectors. The integration of data-driven insights into everyday health routines is not only empowering end users but also opening up new avenues for research and product development, thereby reshaping the industry's financial and operational models.

Key Segmentation Insights Informing Market Strategy

A thorough analysis of market segmentation in the metabolic testing solutions arena reveals a complex framework that integrates various product types, test modalities, measurement parameters, age groups, portability, applications, and end user categories. The industry is segmented based on product type into devices and software & apps, with the former further categorized into multi-use and single-use systems. This dimension reflects how integrated solutions have evolved to address a broad range of diagnostic requirements, offering versatility across different clinical and consumer settings.

Delving deeper into test types, the market distinguishes itself with segments that include biochemical testing, breath testing, and genetic testing. Biochemical testing is further broken down into blood analysis, saliva testing, and urine analysis, emphasizing how each biological fluid offers unique insights into metabolic processes. Breath testing, on the other hand, caters to assessments like resting metabolic rate measurement and VO2 max testing, each serving specific clinical and performance-based needs. These distinctions underscore the importance of tailoring diagnostic products to meet the specific requirements of varied clinical applications.

Further segmentation based on measurement parameters encompasses respiratory quotient, resting metabolic rate, substrate utilization, and total energy expenditure. This metric-based categorization is crucial for precision diagnostics, as it allows for an in-depth understanding of an individual's metabolic efficiency and energy dynamics. Additionally, the market is segmented by age group-adolescent, adult, geriatric, and pediatric-highlighting the necessity to adapt testing protocols according to physiological variations that occur across the lifespan.

The segmentation strategy also considers portability, distinguishing between bench-top and portable systems. This differentiation responds to the evolving demand for both high-capacity testing setups in clinical environments and flexible, mobile solutions for remote or in-home diagnostics. Application-wise, metabolic testing covers clinical diagnostics, health & wellness, population studies, and sports & fitness, with further subdivisions emerging within each category. For instance, clinical diagnostics is dissected into hospitals, laboratories, and specialty clinics; health & wellness spans gyms and weight management facilities; population studies embrace epidemiological and nutritional research; while sports & fitness cater to amateur athletes, fitness enthusiasts, and professional athletes.

Lastly, market segmentation based on end users encompasses fitness centers & gyms, home care settings, hospitals & clinics, research laboratories, and sports academies, with additional layers subdividing segments such as fitness chains and personal training facilities, or professional athlete centers alongside youth training institutes. This nuanced segmentation allows industry stakeholders to pinpoint target audiences accurately and develop tailored strategies that align with both current trends and future market demands.

Based on Product Type, market is studied across Devices and Software & Apps. The Devices is further studied across Multi-Use and Single-Use.

Based on Test Type, market is studied across Biochemical Testing, Breath Testing, and Genetic Testing. The Biochemical Testing is further studied across Blood Analysis, Saliva Testing, and Urine Analysis. The Breath Testing is further studied across Resting Metabolic Rate Measurement and VO2 Max Testing.

Based on Measurement Parameter, market is studied across Respiratory Quotient, Resting Metabolic Rate, Substrate Utilization, and Total Energy Expenditure.

Based on Age Group, market is studied across Adolescent, Adult, Geriatric, and Pediatric.

Based on Portability, market is studied across Bench-top System and Portable System.

Based on Application, market is studied across Clinical Diagnostics, Health & Wellness, Population Studies, and Sports & Fitness. The Clinical Diagnostics is further studied across Hospitals, Laboratories, and Specialty Clinics. The Health & Wellness is further studied across Gyms and Weight Management. The Population Studies is further studied across Epidemiological{ and Nutritional Studies. The Sports & Fitness is further studied across Amateur Athletes, Fitness Enthusiasts, and Professional Athletes.

Based on End User, market is studied across Fitness Centers & Gyms, Home Care Settings, Hospitals & Clinics, Research Laboratories, and Sports Academies. The Fitness Centers & Gyms is further studied across Fitness Chains and Personal Training Facilities. The Sports Academies is further studied across Professional Athlete Centers and Youth Training Institutes.

Key Regional Insights Shaping Global Market Dynamics

Regional dynamics play a pivotal role in determining the growth trajectories within the metabolic testing solutions market. In the Americas, technological advancements and a robust healthcare infrastructure have driven significant adoption of advanced metabolic testing platforms, supported by extensive research initiatives and a high level of consumer awareness. This region commands considerable market influence through a combination of government incentives and proactive private sector engagement in healthcare innovation.

Shifting focus to the Europe, Middle East & Africa region, a blend of mature healthcare systems and emerging markets has spurred a wave of transformative initiatives. Collaborative efforts between governmental bodies and private enterprises in these areas have facilitated the expansion of diagnostic capabilities, thereby enhancing the accessibility and precision of metabolic testing. The convergence of regulatory standards and the increasing emphasis on preventive care are also pivotal factors behind the growth witnessed in this region.

In the Asia-Pacific domain, rapid economic growth combined with expansive healthcare reforms has created an environment ripe for innovation in diagnostic technology. The region is characterized by a dynamic mix of high-end research facilities and an increasing focus on consumer wellness, driving demand for versatile and mobile metabolic testing solutions. The localized adaptation of technological innovations has been instrumental in meeting the diverse needs of a large and varied population, making the Asia-Pacific region an essential arena for market expansion and investment.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Reinforcing Industry Leadership

Industry leadership in metabolic testing solutions is defined by the strategic innovation and market agility demonstrated by key players. Prominent companies such as AEI Technologies, Inc., Agilent Technologies, Inc., BASF SE, Biospace, Inc., CENTOGENE N.V., and COSMED srl have been at the vanguard of technological advancements, continuously refining their products to meet evolving clinical and consumer needs. These companies have nurtured robust research and development pipelines that enable the rapid translation of laboratory breakthroughs into market-ready solutions.

Further cementing industry standards are leading organizations like GE HealthCare, Geratherm Medical AG, ICON plc, and Iworx Systems, whose contributions have set benchmarks in both hardware performance and software innovation. Pioneering firms such as KORR Medical Technologies, Inc. and MGC Diagnostics Corporation, alongside Microlife Medical Home Solutions, Inc., Nicci Schock LLC, Parvo Medics, and PerkinElmer Inc., have expanded the technological boundaries in metabolic testing with solutions that span from sophisticated laboratory systems to user-friendly home care devices.

Additional leadership is evident in the initiatives driven by The Endurance Edge, LLC, Thermo Fisher Scientific Inc., Vacumetrics Inc., and Vyaire Medical, Inc., which illustrate a commitment to addressing niche market demands while consistently pushing forward a culture of scientific excellence and innovation. These market trailblazers have not only responded to current clinical imperatives but have also forecasted future trends, positioning themselves as crucial contributors to an unfolding narrative defined by precision and personalization.

The report delves into recent significant developments in the Metabolic Testing Solutions Market, highlighting leading vendors and their innovative profiles. These include AEI Technologies, Inc.,, Agilent Technologies, Inc, BASF SE, Biospace, Inc., CENTOGENE N.V., COSMED srl, GE HealthCare, Geratherm Medical AG, ICON plc, Iworx Systems, KORR Medical Technologies, Inc, MGC Diagnostics Corporation, Microlife Medical Home Solutions, Inc.,, Nicci Schock LLC, Parvo Medics, PerkinElmer Inc., The Endurance Edge, LLC, Thermo Fisher Scientific Inc., Vacumetrics Inc, and Vyaire Medical, Inc.. Actionable Recommendations for Industry Leaders in Metabolic Testing

To capitalize on emerging opportunities within the metabolic testing space, industry leaders should consider several strategic initiatives. First, invest heavily in research and development to create flexible diagnostic solutions that cater to both specialized clinical demands and broader consumer wellness trends. Emphasizing the integration of multi-modal testing methodologies with real-time analytics will help bridge the gap between conventional diagnostics and personalized medicine.

Furthermore, forging strategic partnerships with technology firms, healthcare providers, and research institutions is critical to accelerating product innovation and market penetration. Leveraging cross-sector collaborations can facilitate the development of integrated platforms that provide comprehensive metabolic profiles and actionable insights. Leaders should also prioritize scalability by designing solutions that adapt seamlessly across various environments-from high-volume clinical laboratories and hospitals to decentralized home care and mobile health applications.

Adopting an agile approach to market segmentation remains vital. By differentiating between product types, test methods, and measurement parameters, companies can fine-tune their offerings to address targeted patient demographics and application areas. Embracing a data-driven strategy will not only optimize product development but also enhance the effectiveness of marketing and distribution channels.

Operational efficiency and customer support are equally important. Streamlined manufacturing processes, robust supply chain management, and responsive after-sales services can elevate a company's competitive edge in this fast-paced sector. Finally, proactive regulatory compliance and attention to emerging international standards will ensure smoother market entry and sustained growth across different regions, thereby positioning companies effectively against a backdrop of rapid technological and market evolution.

Conclusion: Navigating the Future of Metabolic Testing

The comprehensive analysis of metabolic testing solutions reveals a market characterized by rapid innovation, strategic segmentation, and significant regional diversification. The progress from traditional testing methods to integrated suites combining advanced devices and software underscores the transformative potential within this arena. As technological advancements continue to drive the development of more precise and accessible testing options, the market is poised to deliver enhanced diagnostic capabilities that cater to diverse user needs.

Industry stakeholders are recognizing the importance of leveraging detailed segmentation insights and regional dynamics to tailor their strategies in an increasingly competitive environment. With a focus on both established and emerging markets, leaders are refining their approach to product development, operational efficiency, and customer engagement. This forward-thinking approach is not just responding to current market demands but is also paving the way for future innovations that promise to transform the landscapes of clinical diagnostics, health and wellness, and sports performance measurement.

In summary, the evolving narrative of metabolic testing is one of progress and adaptation. By remaining vigilant in monitoring shifts in technology and consumer behavior, decision-makers can utilize these insights to foster sustainable growth and maintain a competitive edge in this exciting and fast-moving field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising consumer awareness and emphasis on fitness and health improving
      • 5.1.1.2. Growing investment in healthcare infrastructure in emerging economies
      • 5.1.1.3. Increasing prevalence of metabolic disorders such as diabetes and obesity
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced metabolic testing solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of telemedicine solutions with metabolic testing to offer remote diagnosis and monitoring
      • 5.1.3.2. Rising trend toward personalized and convenient health monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization in testing procedures and outcomes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising preference for devices due to their durability and cost-effectiveness
    • 5.2.2. End User: Increasing use of metabolic testing solutions in fitness centers and gyms to offer personalized fitness regimes and nutritional plans
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Metabolic Testing Solutions Market, by Product Type

  • 6.1. Introduction
  • 6.2. Devices
    • 6.2.1. Multi-Use
    • 6.2.2. Single-Use
  • 6.3. Software & Apps

7. Metabolic Testing Solutions Market, by Test Type

  • 7.1. Introduction
  • 7.2. Biochemical Testing
    • 7.2.1. Blood Analysis
    • 7.2.2. Saliva Testing
    • 7.2.3. Urine Analysis
  • 7.3. Breath Testing
    • 7.3.1. Resting Metabolic Rate Measurement
    • 7.3.2. VO2 Max Testing
  • 7.4. Genetic Testing

8. Metabolic Testing Solutions Market, by Measurement Parameter

  • 8.1. Introduction
  • 8.2. Respiratory Quotient
  • 8.3. Resting Metabolic Rate
  • 8.4. Substrate Utilization
  • 8.5. Total Energy Expenditure

9. Metabolic Testing Solutions Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adolescent
  • 9.3. Adult
  • 9.4. Geriatric
  • 9.5. Pediatric

10. Metabolic Testing Solutions Market, by Portability

  • 10.1. Introduction
  • 10.2. Bench-top System
  • 10.3. Portable System

11. Metabolic Testing Solutions Market, by Application

  • 11.1. Introduction
  • 11.2. Clinical Diagnostics
    • 11.2.1. Hospitals
    • 11.2.2. Laboratories
    • 11.2.3. Specialty Clinics
  • 11.3. Health & Wellness
    • 11.3.1. Gyms
    • 11.3.2. Weight Management
  • 11.4. Population Studies
    • 11.4.1. Epidemiological{
    • 11.4.2. Nutritional Studies
  • 11.5. Sports & Fitness
    • 11.5.1. Amateur Athletes
    • 11.5.2. Fitness Enthusiasts
    • 11.5.3. Professional Athletes

12. Metabolic Testing Solutions Market, by End User

  • 12.1. Introduction
  • 12.2. Fitness Centers & Gyms
    • 12.2.1. Fitness Chains
    • 12.2.2. Personal Training Facilities
  • 12.3. Home Care Settings
  • 12.4. Hospitals & Clinics
  • 12.5. Research Laboratories
  • 12.6. Sports Academies
    • 12.6.1. Professional Athlete Centers
    • 12.6.2. Youth Training Institutes

13. Americas Metabolic Testing Solutions Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Metabolic Testing Solutions Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Metabolic Testing Solutions Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. Calorify's innovative metabolic testing solutions democratize access to critical health insights
    • 16.3.2. Truvian Health raises USD 74 million to innovate the future of accessible and efficient blood diagnostics
    • 16.3.3. Labcorp transforms weight loss management with new testing solutions to optimize health outcomes
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AEI Technologies, Inc.,
  • 2. Agilent Technologies, Inc
  • 3. BASF SE
  • 4. Biospace, Inc.
  • 5. CENTOGENE N.V.
  • 6. COSMED srl
  • 7. GE HealthCare
  • 8. Geratherm Medical AG
  • 9. ICON plc
  • 10. Iworx Systems
  • 11. KORR Medical Technologies, Inc
  • 12. MGC Diagnostics Corporation
  • 13. Microlife Medical Home Solutions, Inc.,
  • 14. Nicci Schock LLC
  • 15. Parvo Medics
  • 16. PerkinElmer Inc.
  • 17. The Endurance Edge, LLC
  • 18. Thermo Fisher Scientific Inc.
  • 19. Vacumetrics Inc
  • 20. Vyaire Medical, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦